Skip to main content
Log in

Changes in human umbilical vein endothelial cells induced by endothelial nitric oxide synthase traffic inducer

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

This study investigated the changes in human umbilical vein endothelial cells (HUVECs) induced by overexpression of endothelial nitric oxide synthase traffic inducer (NOSTRIN) and its role in cellular injury. Recombinant NOSTRIN-expressing and empty vectors were transfected into cultured HUVECs, and factor VIII-related antigen was examined by using immunohistochemical analysis. Growth curves were generated for both transfected and untransfected cells and these indicated that the proliferative ability of cells overexpressing NOSTRIN was significantly decreased. The expression of NOSTRIN and eNOS proteins was detected by using Western blot analysis, endothelial NOS (eNOS) activity was assayed by using spectrophotometry, and NO2 /NO3 levels were measured using nitrate reductase. Immunohistochemical analysis demonstrated that all groups expressed NOSTRIN in the plasma membrane and cytoplasm, and Western blot analysis confirmed that NOSTRIN levels were significantly higher in cells transfected with the NOSTRIN plasmid (P<0.01). The activity of eNOS and the levels of NO2 /NO3 were significantly decreased in NOSTRIN overexpressing cells as compared with empty vector and untransfected cells (P<0.01 and P<0.01, respectively). Morphological and ultrastructural changes were observed under light and electron microscopy, and it was found that NOSTRIN-overexpressing cells were elongated with deformities of the karyotheca, injury to the plasma membrane, increased lipids in the cytoplasm, and shortened microvilli. This study showed that overexpression of NOSTRIN had a significant effect on eNOS activity in HUVECs and resulted in significant cellular damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rudic RD, Shesely EG, Maeda N, et al. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest, 1998,101(4):731–736

    Article  PubMed  CAS  Google Scholar 

  2. Gonzalez E, Kou R, Lin AJ, et al. Subcellular targeting and agonist-induced site-specific phosphorylation of endothelial nitric-oxide synthase. J Biol Chem, 2002,277(42):39 554–39 560

    Article  CAS  Google Scholar 

  3. Michel JB, Foron O, Sase K, et al. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem, 1997,272(41):25 907–25 912

    Article  CAS  Google Scholar 

  4. García-Cardeña G, Fan R, Stern DF, et al. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem, 1996,271(44):27 237–27 240

    Google Scholar 

  5. García-Cardeña G, Fan R, Shah V, et al. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature, 1998,392(6678):821–824

    Article  PubMed  Google Scholar 

  6. Zimmermann K, Opitz N, Dedio J, et al. NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase. Proc Natl Acad Sci USA, 2002,99(26):17 167–17 172

    Article  CAS  Google Scholar 

  7. Xiang W, Chen H, Xu X, et al. Expression of endothelial nitric oxide synthase traffic inducer in the placentas of women with pre-eclampsia. Int J Gynaecol Obstet, 2005,89(2):103–107

    Article  PubMed  CAS  Google Scholar 

  8. Xiang W, Chen H, Hu L, et al. Endothelial nitric oxide synthase traffic inducer in the umbilical vessels of the patients with pre-eclampsia. J Huazhong Univ Sci Technol Med Sci, 2009,29(2):243–245

    Article  PubMed  CAS  Google Scholar 

  9. Feron O, Saldana F, Michel JB, et al. The endothelial nitric oxide synthase -caveolin regulatory cycle. J Biol Chem, 1998,273(6):3125–3128

    Article  PubMed  CAS  Google Scholar 

  10. Prabhakar P, Thatte HS, Goetz RM, et al. Receptor-regulated translocation of endothelial nitric-oxide synthase. J Biol Chem, 1998,273(42):27 383–27 388

    Article  CAS  Google Scholar 

  11. Ju H, Zou R, Venema VJ, et al. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Cell, 1997,8(4):595–605

    Google Scholar 

  12. Schilling K, Opitz N, Wiesenthal A, et al. Translocation of endothelial nitricoxide synthase involves a ternary complex with caveolin-1 and NOSTRIN. Mol Biol Cell, 2006,17(9):3870–3880

    Article  PubMed  CAS  Google Scholar 

  13. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev, 1991,43(2):109–142

    PubMed  CAS  Google Scholar 

  14. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet, 1989,2(8670):997–1000

    Article  PubMed  CAS  Google Scholar 

  15. Cannon RO 3rd. Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin Chem, 1998,44(8 Pt 2):1809–1819

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wen-pei Xiang  (相文佩).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, Xy., Pang, Wj., Wen, Zn. et al. Changes in human umbilical vein endothelial cells induced by endothelial nitric oxide synthase traffic inducer. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 33, 272–276 (2013). https://doi.org/10.1007/s11596-013-1110-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-013-1110-2

Key words

Navigation